ORCHESTRA BIOMED HOLDINGS INC. - ORDINARY SHARES

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

29 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

28 Apr 2025 15:30:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

23 Apr 2025 08:00:13 By Nasdaq GlobeNewswire

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

22 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

31 Mar 2025 15:21:30 By Nasdaq GlobeNewswire

Orchestra BioMed to Present at Upcoming Investor Conferences

20 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

18 Feb 2025 07:00:01 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

12 Feb 2025 09:43:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

05 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting

09 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference

26 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

12 Nov 2024 15:12:39 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update

12 Aug 2024 15:20:20 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors

30 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

04 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Participate in Jefferies Global Healthcare Conference

22 May 2024 07:43:18 By Nasdaq GlobeNewswire

Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update

13 May 2024 15:58:13 By Nasdaq GlobeNewswire

Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents

30 Apr 2024 07:30:00 By Nasdaq GlobeNewswire

Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire